|
|
Volumn 105, Issue 21, 2002, Pages
|
|
Activating effects of GPIIb/IIIa blockers: an intrinsic consequence of ligand-mimetic properties.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN;
FIBRINOGEN RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
LIGAND;
MONOCLONAL ANTIBODY;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYME SPECIFICITY;
HUMAN;
METABOLISM;
NOTE;
PROTEIN CONFORMATION;
THROMBOCYTE;
THROMBOCYTE ACTIVATION;
ANTIBODIES, MONOCLONAL;
BLOOD PLATELETS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FIBRINOGEN;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
LIGANDS;
PLATELET ACTIVATION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PROTEIN CONFORMATION;
SUBSTRATE SPECIFICITY;
MLCS;
MLOWN;
|
|
EID: 0037188668
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.0000017280.72394.1f Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
